glp 1 controversy Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding Hims & Hers, and the

June 2, 2026

Glucagon-like peptide-1 agonists (GLP-1s) have been in the spotlight as demand has grown to support type 2 diabetes and weight loss

Whether it is TIDM or TIIDM, if patients do not treat their hyperglycemia through appropriate medical interventions, they may face a series of severe consequences like blindness, kidney failure, or amputation.

Prices in the UK start from 1.99 at Ashcroft Pharmacy.

Easily toss them in your bag, purse, or gym bag for instant nutrition anytime, anywhere

| Novo Nordisk and Hims & Hers struck a truce after sparring over compounded versions of the pharma giant's branded GLP-1 drugs